Pediatrix Medical Group, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: John M. Starcher, Jr.

Pediatrix Medical Group, Inc.’s own tally for this item (“Elect Director: John M. Starcher, Jr.”): 46,296,745 for, 25,909,618 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for the Company's Board of Directors were elected to serve until the Company's 2027 Annual Shareholders' Meeting or until their respectiv…”
Support: 64% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 108 asset managers below reported 31,794,728 for, 13,444,095 against, 3,834 abstained.

Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.

Description as filed by funds: Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Kurt D. Newman, M.D.

Pediatrix Medical Group, Inc.’s own tally for this item (“Elect Director: Kurt D. Newman, M.D.”): 71,922,039 for, 256,292 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for the Company's Board of Directors were elected to serve until the Company's 2027 Annual Shareholders' Meeting or until their respectiv…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 108 asset managers below reported 45,276,318 for, 2,482 against, 1,857 abstained.

Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.

Description as filed by funds: Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Guy P. Sansone

Pediatrix Medical Group, Inc.’s own tally for this item (“Elect Director: Guy P. Sansone”): 70,738,837 for, 1,475,369 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for the Company's Board of Directors were elected to serve until the Company's 2027 Annual Shareholders' Meeting or until their respectiv…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 107 asset managers below reported 44,980,137 for, 255,130 against, 3,834 abstained.

Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.

Description as filed by funds: Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Laura A. Linynsky

Pediatrix Medical Group, Inc.’s own tally for this item (“Elect Director: Laura A. Linynsky”): 71,249,187 for, 967,057 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for the Company's Board of Directors were elected to serve until the Company's 2027 Annual Shareholders' Meeting or until their respectiv…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 107 asset managers below reported 45,118,816 for, 156,428 against, 1,857 abstained.

Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.

Description as filed by funds: Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Mark S. Ordan

Pediatrix Medical Group, Inc.’s own tally for this item (“Elect Director: Mark S. Ordan”): 69,958,141 for, 2,259,130 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for the Company's Board of Directors were elected to serve until the Company's 2027 Annual Shareholders' Meeting or until their respectiv…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 107 asset managers below reported 44,987,219 for, 248,046 against, 3,834 abstained.

Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.

Description as filed by funds: Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Michael A. Rucker

Pediatrix Medical Group, Inc.’s own tally for this item (“Elect Director: Michael A. Rucker”): 70,689,577 for, 1,523,843 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for the Company's Board of Directors were elected to serve until the Company's 2027 Annual Shareholders' Meeting or until their respectiv…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 107 asset managers below reported 44,980,137 for, 255,130 against, 3,834 abstained.

Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.

Description as filed by funds: Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Shirley A. Weis

Pediatrix Medical Group, Inc.’s own tally for this item (“Elect Director: Shirley A. Weis”): 70,725,919 for, 1,478,539 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for the Company's Board of Directors were elected to serve until the Company's 2027 Annual Shareholders' Meeting or until their respectiv…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 107 asset managers below reported 44,980,137 for, 255,130 against, 3,834 abstained.

Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.

Description as filed by funds: Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Sylvia J. Young

Pediatrix Medical Group, Inc.’s own tally for this item (“Elect Director: Sylvia J. Young”): 71,257,572 for, 963,152 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for the Company's Board of Directors were elected to serve until the Company's 2027 Annual Shareholders' Meeting or until their respectiv…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 107 asset managers below reported 45,080,816 for, 156,427 against, 1,857 abstained.

Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.

Description as filed by funds: Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Thomas A. McEachin

Pediatrix Medical Group, Inc.’s own tally for this item (“Elect Director: Thomas A. McEachin”): 70,107,436 for, 2,093,168 against, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for the Company's Board of Directors were elected to serve until the Company's 2027 Annual Shareholders' Meeting or until their respectiv…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 107 asset managers below reported 44,597,449 for, 675,817 against, 3,834 abstained.

Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.

The 109 asset managers below reported 41,942,654 for, 3,222,712 against, 1,857 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

Description as filed by funds: Conduct an advisory vote regarding the compensation of our named executive officers for the 2025 fiscal year; and

Pediatrix Medical Group, Inc.’s own tally for this item (“3. On a non-binding, advisory basis, the compensation of the Company's named executive officers for the 2025 fiscal year”): 70,257,832 for, 1,960,931 against — passed, per its Form 8-K filed May 7, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: The Company's shareholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the 2025 fiscal year, by the votes set forth in the table below:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 105 managers: 45,057,341 for, 179,404 against, 1,857 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 263 managers: 40,342,251 for, 772,918 against, 3,788 abstained, 67 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2026 fiscal year;

Pediatrix Medical Group, Inc.’s own tally for this item (“2. Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year”): 75,519,473 for, 1,794,278 against — passed, per its Form 8-K filed May 7, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year was ratified by the Company's shareholders, by the votes set forth in the table below:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 108 asset managers below reported 44,751,497 for, 489,302 against, 1,857 abstained.

Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.